Literature DB >> 9393173

Altered intravascular contrast material flow dynamics: clues for refining thoracic CT diagnosis.

M V Gosselin1, G D Rubin.   

Abstract

The ability of helical thoracic CT to acquire data rapidly has enabled radiologists to use the dynamics of contrast medium flow more effectively to diagnose subtle abnormalities. In general, these abnormal flow dynamics manifest in two ways: diverted hyperdense venous opacification and an altered temporal relationship of vascular opacification. When observed, these findings serve as clues for the detection of elusive anatomic and physiologic abnormalities.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393173     DOI: 10.2214/ajr.169.6.9393173

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

1.  Septal bowing and pulmonary artery diameter on computed tomography pulmonary angiography are associated with short-term outcomes in patients with acute pulmonary embolism.

Authors:  Mads Dam Lyhne; Jacob Gammelgaard Schultz; Peter J MacMahon; Faris Haddad; Mannudeep Kalra; David Mai-King Tso; Alona Muzikansky; Michael H Lev; Christopher Kabrhel
Journal:  Emerg Radiol       Date:  2019-08-02

Review 2.  Hemodynamic indexes derived from computed tomography angiography to predict pulmonary embolism related mortality.

Authors:  Gregor John; Christophe Marti; Pierre-Alexandre Poletti; Arnaud Perrier
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

3.  Contrast Circulation Time to Assess Right Ventricular Dysfunction in Pulmonary Embolism: A Retrospective Pilot Study.

Authors:  Gregor John; Alexandra Platon; Pierre-Alexandre Poletti; Arnaud Perrier; Karim Bendjelid
Journal:  PLoS One       Date:  2016-08-23       Impact factor: 3.240

4.  Hepatic Pseudolesion due to "Vein of Sappey" in Superior Vena Cava Syndrome.

Authors:  Shitalmala Devi; Thangjam Gautam Singh; Reema Ningthoukhongjam
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.